Increased intakes of soy and soy products may reduce the risk of death and breast cancer recurrence, says a new study in the Journal of the American Medical Association.
Flavour and ingredients company Frutarom has launched a slimming campaign based on what it describes as “highly effective but natural and clean label slimming products.”
For a fruit that has had more science conducted on it than most, it is surprising to some that France remains the only country to have approved a long-standing cranberry...
The countdown is on – only one day remains before the NutraIngredients Health Claims 2010 conference unpicks the problematic and controversial regulation.
The penetration of Asian markets by functional ingredients manufacturers continues apace with the launch of a juice containing cholesterol lowering plant sterols and stanols in the Philippines.
British National Health Service dietician, Katie Peck is facing a disciplinary hearing conducted by the Health Professions Council (HPC) after recommending functional foods and allegedly displaying lack of competence.
A compound often discarded as waste in soy-processing plants may stop inflammation, and protect against chronic diseases like diabetes and heart disease, says new research.
In the third part of our special series on cranberries, NutraIngredients looks at the science behind the reported health benefits of the little red berry.
Return to profitability. It’s a phrase that businesses have been yearning for, but as more of them are starting to use it, it’s time to ask: At what cost?...
The Irish Health Trade Association (IHTA) claims the scientific approach taken by the European Food Safety Authority (EFSA) in its assessment of health claims for nutrients is seriously flawed.
India is developing guidelines that may mean probiotic strains will have to be backed by clinical trials conducted on Indian populations if they are to gain market approval.
Following approval as an ingredient allowed to be used in food supplements in the EU, Nutrition 21 has announced a distribution agreement for chromium picolinate.
Increased intakes of magnesium may reduce the risk of coronary heart disease (CHD) in men, but the evidence is lacking for women, says a new review.
In the second part of our special on cranberries, NutraIngredients looks at the supply for the berry, and asks ‘what issues are bogging down cranberry supply?’
The campaign to ensure higher potency food supplements can remain on the UK market is stepping up a gear with a motion tabled in the UK Parliament seeking the prime...
As the European Union health claims climate evolves, companies are learning just what is required to demonstrate the benefits of healthy foods and supplements.
Consumption of polyphenol-rich dark chocolate may protect DNA from oxidative damage, preventing artery hardening and heart disease, says a new study.
Scottish omega-3 supplier, Equateq, has added to its range by blending a high-dose EPA omega-3 form with whey in a debut targeting the sports market.
In the first of a four part special edition focused on cranberries, NutraIngredients looks at the market for the berry, with its entrance into the indulgence sectors an indication perhaps...
UK biotech firm Provexis has released six month results for the period ending September 30 that reveal up to €7.8m in raised capital.
Supplements of French maritime pine bark extract may improve the flow of blood in the tiny blood vessels of the retina, and enhance sight in diabetics with early stage eye...
Folic acid supplements during pregnancy may not only reduce the risk of birth defects but also protect the children from congenital heart defects, says a new study from the Netherlands.
As a raft of non-positive opinions on probiotics floats down the health claims river, questions have been asked of the efficacy of the beneficial bacteria. Two experts discuss where we...
UK-based omega-3 supplements brand, Equazen, says it will amend its marketing materials after negative health claim opinions regarding its products were written into the European Union legislature in October.
Probiotics should be considered as living drugs rather than “simple good bacteria” in order to become effective treatment options for IBS, according to Joseph Haddad, medical director of Institut Rosell-Lallemand.